Hisato Hara

1.3k total citations
60 papers, 875 citations indexed

About

Hisato Hara is a scholar working on Oncology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hisato Hara has authored 60 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Cancer Research and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hisato Hara's work include Thyroid Cancer Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Adrenal and Paraganglionic Tumors (7 papers). Hisato Hara is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Adrenal and Paraganglionic Tumors (7 papers). Hisato Hara collaborates with scholars based in Japan, United States and Pakistan. Hisato Hara's co-authors include Tohru Yashiro, Hiroko Bando, Yasushi Kawakami, Kazuhiro Takekoshi, Kiyo‐aki Ishii, Takao Obara, Ei Ueno, Hitoshi Shimano, Yukiko Yano and Yuji Aiyoshi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Hisato Hara

55 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hisato Hara Japan 17 349 256 223 198 183 60 875
Madhuchhanda Roy United States 15 280 0.8× 100 0.4× 383 1.7× 95 0.5× 135 0.7× 32 918
Tamara Aleksic United Kingdom 15 245 0.7× 258 1.0× 454 2.0× 219 1.1× 130 0.7× 18 786
Svetislav Tatić Serbia 18 265 0.8× 459 1.8× 321 1.4× 167 0.8× 186 1.0× 75 962
Ning Qu China 22 283 0.8× 623 2.4× 358 1.6× 209 1.1× 310 1.7× 64 1.2k
Peter Gaßmann Germany 16 381 1.1× 81 0.3× 238 1.1× 119 0.6× 128 0.7× 23 858
Jin Hyung Heo South Korea 16 111 0.3× 99 0.4× 528 2.4× 374 1.9× 121 0.7× 38 860
Marilyn M. Giacomini United States 7 247 0.7× 42 0.2× 340 1.5× 82 0.4× 160 0.9× 8 1.0k
Hidemi Kawajiri Japan 15 519 1.5× 45 0.2× 253 1.1× 259 1.3× 94 0.5× 67 857
Tetsushi Saishoji Japan 11 206 0.6× 83 0.3× 294 1.3× 155 0.8× 85 0.5× 15 717
Javier Molina‐Cerrillo Spain 17 384 1.1× 81 0.3× 342 1.5× 249 1.3× 154 0.8× 66 967

Countries citing papers authored by Hisato Hara

Since Specialization
Citations

This map shows the geographic impact of Hisato Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisato Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisato Hara more than expected).

Fields of papers citing papers by Hisato Hara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisato Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisato Hara. The network helps show where Hisato Hara may publish in the future.

Co-authorship network of co-authors of Hisato Hara

This figure shows the co-authorship network connecting the top 25 collaborators of Hisato Hara. A scholar is included among the top collaborators of Hisato Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisato Hara. Hisato Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugitani, Iwao, Naomi Kiyota, Yasuhiro Ito, et al.. (2025). The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery. Endocrine Journal. 72(5). 545–635. 5 indexed citations
2.
Tahara, Makoto, Hiroshi Takami, Yasuhiro Ito, et al.. (2024). A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer. Thyroid. 34(5). 566–574. 9 indexed citations
3.
Yoshitomi, Toru, Naoki Kawazoe, Guoping Chen, et al.. (2024). Effective disruption of cancer cell membranes by photodynamic therapy with cell membrane-adhesive photosensitizer. Journal of Clinical Biochemistry and Nutrition. 75(3). 197–203. 1 indexed citations
5.
Matsumura, Hiroki, Akihiro Isozaki, Hideharu Mikami, et al.. (2023). Virtual-freezing fluorescence imaging flow cytometry with 5-aminolevulinic acid stimulation and antibody labeling for detecting all forms of circulating tumor cells. Lab on a Chip. 23(6). 1561–1575. 8 indexed citations
6.
Bando, Hiroko, et al.. (2022). Absolute Lymphocyte Count as an Independent Prognostic Factor in Metastatic Breast Cancer: A Retrospective Study. Oncology. 100(11). 591–601. 5 indexed citations
7.
Higashiyama, Takuya, Kiminori Sugino, Hisato Hara, et al.. (2022). Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE). European Journal of Cancer. 173. 210–218. 32 indexed citations
8.
Noguchi, Emiko, et al.. (2020). Neoantigen prediction in human breast cancer using RNA sequencing data. Cancer Science. 112(1). 465–475. 17 indexed citations
9.
Iguchi‐Manaka, Akiko, et al.. (2018). Preoperative diagnosis of a giant cell tumor of soft tissue arising from the breast by ultrasound-guided core needle biopsy. Journal of Medical Ultrasonics. 46(2). 257–261. 5 indexed citations
10.
Chiba, Tomohiro, et al.. (2017). Effects of sorafenib and an adenylyl cyclase activator on <i>in vitro</i> growth of well-differentiated thyroid cancer cells. Endocrine Journal. 64(11). 1115–1123. 2 indexed citations
11.
Shiraishi, Akira, Masumi Nagano, Toshiki Kato, et al.. (2016). Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells. Cancer Science. 108(3). 362–372. 43 indexed citations
12.
Iguchi‐Manaka, Akiko, Takehiro Oikawa, Takeshi Saito, et al.. (2016). A case of hemorrhagic cystitis caused by nab-paclitaxel. International Cancer Conference Journal. 5(4). 187–191. 2 indexed citations
13.
Tanaka, Yuko, et al.. (2014). Glomus tumor of a female breast: a case report and review of the literature. Journal of Medical Ultrasonics. 41(3). 385–388. 8 indexed citations
14.
Dai, Yuichi, et al.. (2014). A case of breast cholesterol granuloma presenting twinkling artifact on color Doppler sonography. Choonpa Igaku. 41(6). 867–870.
15.
Fukuda, Taeko, et al.. (2011). Tracheomalacia after reoperation for an adenomatous goiter located in a unique position. Journal of Anesthesia. 25(5). 745–748. 7 indexed citations
16.
Tanaka, Yuko, Yuichi Aita, Kiyo‐aki Ishii, et al.. (2011). Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD. American Journal of Physiology-Endocrinology and Metabolism. 302(6). E615–E625. 50 indexed citations
17.
Watanabe, Masahiko, Akimitsu Takahashi, Hitoshi Shimano, et al.. (2010). Thunderclap headache without hypertension in a patient with pheochromocytoma. The Journal of Headache and Pain. 11(5). 441–444. 4 indexed citations
18.
Isobe, Kazumasa, Hideto Takahashi, Hisato Hara, et al.. (2009). Adiponectin and Adiponectin Receptors in Human Pheochromocytoma. Journal of Atherosclerosis and Thrombosis. 16(4). 442–447. 12 indexed citations
19.
Takekoshi, Kazuhiro, Kazumasa Isobe, Tohru Yashiro, et al.. (2003). Expression of vascular endothelial growth factor (VEGF) and its cognate receptors in human pheochromocytomas. Life Sciences. 74(7). 863–871. 28 indexed citations
20.
Hara, Hisato, Hiroyuki Yamazaki, Hideki Hayashi, et al.. (1986). CLINICAL INVESTIGATION OF PANCREAS DIVISUM ASSOCIATED WITH PANCREATITIS. Acta gastro-enterologica belgica. 28(3). 562–568. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026